The companies had announced a collaboration in April for Hims & Hers to sell Novo's Wegovy through an offering on the telehealth company's platform.

Infection, delayed kidney function, kidney loss and death are all risks associated with kidney transplant surgery in obese ...

GPs in England are now allowed to prescribe Mounjaro to severely obese people who also suffer from a range of other health ...

Novo Nordisk ends partnership with Hims & Hers over compounded Wegovy, shaking the market. See why I recommend a wait-and-see ...

( NewsNation) — Novo Nordisk has ended a partnership with U.S. telehealth company Hims & Hers, citing deceptive marketing and ...

Mounjaro offers up to 20% weight loss – but it’s not for everyone. Learn about eligibility, alternatives and why long-term ...

Stocks were slightly higher in early-afternoon trading Monday as investors reacted calmly to news that the U.S. bombed three nuclear sites in Iran over the weekend.

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the ...

Hims & Hers stock plunged around 30% on Monday after drugmaker Novo Nordisk abruptly ended a month-long collaboration to make ...

Novo Nordisk said it's ending its collaboration due to concerns with Hims & Hers the company's sales and promotion of cheap ...

Hims & Hers ( HIMS) stock plummeted around 30% in early trading Monday after Novo Nordisk ( NVO) announced it was ending a ...